Clinofibrate
Cat.No:IC3890 Solarbio
CAS:30299-08-2
Molecular Formula:C28H36O6
Molecular Weight:468.58
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Metabolic Enzyme & Protease >
ClinofibrateCAS:30299-08-2
Molecular Formula:C28H36O6
Molecular Weight:468.58
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 30299-08-2 |
Name | Clinofibrate |
Molecular Formula | C28H36O6 |
Molecular Weight | 468.58 |
Solubility | Soluble in DMSO ≥5mg/mL |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 1312995-182-4 |
MDL | MFCD00865769 |
SMILES | CCC(OC1=CC=C(C2(C3=CC=C(OC(CC)(C)C(O)=O)C=C3)CCCCC2)C=C1)(C)C(O)=O |
InChIKey | BMOVQUBVGICXQN-UHFFFAOYSA-N |
InChI | InChI=1S/C28H36O6/c1-5-26(3,24(29)30)33-22-14-10-20(11-15-22)28(18-8-7-9-19-28)21-12-16-23(17-13-21)34-27(4,6-2)25(31)32/h10-17H,5-9,18-19H2,1-4H3,(H,29,30)(H,31,32) |
PubChem CID | 2787 |
Target Point | HMG-CoA Reductase (HMGCR) |
Passage | Metabolic Enzyme&Protease |
Background | Clinofibrate inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR) (hydroxymethylglutaryl coenzyme A reductase), a lipid-lowering agent used to control high cholesterol and triglyceride levels in the blood. |
Biological Activity | Clinofibrate (S-8527)是一种降血脂药和一种HMG-CoA还原酶抑制剂。[1-4] |
Data Literature Source | [1]. Okazaki M,et al. Effects of clinofibrate on plasma fibrinogen level in high fructose diet-induced hyperlipidemic rats. In Vivo. 1994 Nov-Dec;8(6):1057-61. [2]. Shirai K,et al. Effect of clinofibrate on lipid metabolism of aorta in atherosclerotic rats. Artery. 1983;12(3):145-55. [3]. Suzuki K,et al. Effects of S-8527 (1,1-bis4'-(1'-carboxy'1'-methylpropoxy)-phenyl)-cyclohexane),a new hypolipidemic compound,on triglyceride metablolism in rats. Biochem Pharmacol. 1975 Jun 15;24(11-12):1203-7. [4]. Suzuki K,et al. Hypolipidemic effect of a new aryloxy compound,S-8527,in experimental animals. Jpn J Pharmacol. 1974 Jun;24(3):407-14. |
Unit | Bottle |
Specification | 5mg 10mg 25mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.